← European Medicine Shortage Tracker · all medicines

Lipegfilgrastim shortage — availability across Europe

Lipegfilgrastim currently has availability issues reported in 1 European register: Ireland.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: lipegfilgrastim · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Lipegfilgrastim, covering 1 affected product presentation. The longest-running open report was filed in Ireland on 2026-06-04 and has now been open for about 2 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇪 IrelandShortage
Lonquex 6 mg / 0.6 ml solution for injection EU/1/13/856/005 Teva B.V.
2026-06-042026-08-01Manufacturing delay (Multiple countries)
Alternatives: Alternative(s) available — see the national register.
register ↗

Full report history (1 register entry)

Every individual register entry for Lipegfilgrastim in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇪 IELonquex 6 mg / 0.6 ml solution for injection EU/1/13/856/005 Teva B.V.Shortage2026-06-042026-08-01Manufacturing delay (Multiple countries)

Frequently asked

Is Lipegfilgrastim currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Lipegfilgrastim?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Lipegfilgrastim availability data come from?

Directly from the official medicines-agency register that lists Lipegfilgrastim: HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Lipegfilgrastim — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lipegfilgrastim/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Lipegfilgrastim availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lipegfilgrastim/">Lipegfilgrastim shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Lipegfilgrastim: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.